Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fupin Hu

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
Nature Communications|April 8, 2022
Collateral sensitivity to pleuromutilins in vancomycin-resistant Enterococcus faeciumQian Li, Shang Chen, Kui Zhu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2024
Adaptive evolution of carbapenem-resistant hypervirulent <i>Klebsiella pneumoniae</i> in the urinary tract of a single patientShikai Song, Shixin Yang, Ruicheng Zheng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2020
In Vitro Activity of Imipenem/Relebactam Against Enterobacteriaceae Isolates Obtained from Intra-abdominal, Respiratory Tract, and Urinary Tract Infections in China: Study for Monitoring Antimicrobial Resistance Trends (SMART), 2015-2018Qiwen Yang, Hui Zhang, Yunsong Yu, et al.
Infection and Drug Resistance|April 28, 2025
Establishing Sitafloxacin Epidemiological Cut-off Values (ECOFFs) for Clinical Bacterial IsolatesJingjia Zhang, Xue Li, Xinmiao Jia, et al.
Nature Communications|January 18, 2019
A diversity-oriented rhodamine library for wide-spectrum bactericidal agents with low inducible resistance against resistant pathogensXiao Luo, Liujia Qian, Yansheng Xiao, et al.
Antibiotics (Basel, Switzerland)|June 24, 2022
Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose RegimenYaxin Fan, Yi Li, Yuancheng Chen, et al.
The Lancet. Microbe|October 6, 2022
Distribution and spread of the mobilised RND efflux pump gene cluster tmexCD-toprJ in clinical Gram-negative bacteria: a molecular epidemiological studyNing Dong, Yu Zeng, Yao Wang, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2021
Establishment of epidemiological cut-off values for cefoselis, a new fourth-generation cephalosporin, against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis and Pseudomonas aeruginosaXue Li, Peiyao Jia, Ying Zhu, et al.
Frontiers in Cellular and Infection Microbiology|January 2, 2023
A multicenter investigation of 2,773 cases of bloodstream infections based on China antimicrobial surveillance network (CHINET)Fupin Hu, Lili Yuan, Yang Yang, et al.
The Journal of Antimicrobial Chemotherapy|October 15, 2020
Determination of norvancomycin epidemiological cut-off values (ECOFFs) for Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus hominisQiwen Yang, Xue Li, Peiyao Jia, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Nature Communications|April 8, 2022
Collateral sensitivity to pleuromutilins in vancomycin-resistant Enterococcus faeciumQian Li, Shang Chen, Kui Zhu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2024
Adaptive evolution of carbapenem-resistant hypervirulent <i>Klebsiella pneumoniae</i> in the urinary tract of a single patientShikai Song, Shixin Yang, Ruicheng Zheng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 28, 2020
In Vitro Activity of Imipenem/Relebactam Against Enterobacteriaceae Isolates Obtained from Intra-abdominal, Respiratory Tract, and Urinary Tract Infections in China: Study for Monitoring Antimicrobial Resistance Trends (SMART), 2015-2018Qiwen Yang, Hui Zhang, Yunsong Yu, et al.
Infection and Drug Resistance|April 28, 2025
Establishing Sitafloxacin Epidemiological Cut-off Values (ECOFFs) for Clinical Bacterial IsolatesJingjia Zhang, Xue Li, Xinmiao Jia, et al.
Nature Communications|January 18, 2019
A diversity-oriented rhodamine library for wide-spectrum bactericidal agents with low inducible resistance against resistant pathogensXiao Luo, Liujia Qian, Yansheng Xiao, et al.
Antibiotics (Basel, Switzerland)|June 24, 2022
Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose RegimenYaxin Fan, Yi Li, Yuancheng Chen, et al.
The Lancet. Microbe|October 6, 2022
Distribution and spread of the mobilised RND efflux pump gene cluster tmexCD-toprJ in clinical Gram-negative bacteria: a molecular epidemiological studyNing Dong, Yu Zeng, Yao Wang, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2021
Establishment of epidemiological cut-off values for cefoselis, a new fourth-generation cephalosporin, against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Proteus mirabilis and Pseudomonas aeruginosaXue Li, Peiyao Jia, Ying Zhu, et al.
Frontiers in Cellular and Infection Microbiology|January 2, 2023
A multicenter investigation of 2,773 cases of bloodstream infections based on China antimicrobial surveillance network (CHINET)Fupin Hu, Lili Yuan, Yang Yang, et al.
The Journal of Antimicrobial Chemotherapy|October 15, 2020
Determination of norvancomycin epidemiological cut-off values (ECOFFs) for Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus hominisQiwen Yang, Xue Li, Peiyao Jia, et al.
Pageof 18